Palomino Laboratories (PALX) Gains from Investment Securities (2025)
Palomino Laboratories' (PALX) quarterly Gains from Investment Securities came in at $1.5 million in Q3 2025, down 25.0% quarter-over-quarter from $2.0 million in Q1 2025.
Palomino Laboratories (PALX) Gains from Investment Securities (2025) Analysis & Trends
Palomino Laboratories has disclosed Gains from Investment Securities across 1 years of filings, most recently posting $1.5 million for Q3 2025.
- Gains from Investment Securities for Q3 2025 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1.5 million (changed N/A YoY), and the FY2024 annual result was $58.0, changed 0.0% from the prior year.
- Gains from Investment Securities came in at $1.5 million for Q3 2025 at Palomino Laboratories, down from $2.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.0 million in Q1 2025 to a low of $1.5 million in Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |